Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy-Reference-Cited by-同舟云学术

Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy

Published:2016-06-03 Issue:6 Volume:139 Page:1402-1413
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Radujkovic Aleksandar¹,Dietrich Sascha¹,Andrulis Mindaugas²³,Benner Axel⁴,Longerich Thomas³⁵,Pellagatti Andrea⁶,Nanda Kriti¹,Giese Thomas⁷,Germing Ulrich⁸,Baldus Stefan⁹,Boultwood Jacqueline⁶,Ho Anthony D.¹,Dreger Peter¹,Luft Thomas¹

Affiliation:

1. Department of Internal Medicine V; University Hospital Heidelberg; Heidelberg Germany

2. Institute of Pathology, University of Ulm; Ulm Germany

3. Institute of Pathology, University Hospital Heidelberg; Heidelberg Germany

4. Division of Biostatistics; German Cancer Research Center; Heidelberg Germany

5. Institute of Pathology, University Hospital RWTH Aachen; Aachen Germany

6. Bloodwise Molecular Hematology Unit, NDCLS, University of Oxford; Oxford United Kingdom

7. National Center for Tumor Diseases and Institute of Immunology, University of Heidelberg; Heidelberg Germany

8. Department of Hematology; Oncology and Clinical Immunology, University Hospital Düsseldorf; Düsseldorf Germany

9. Institute of Pathology, University Hospital Düsseldorf; Düsseldorf Germany

Funder

B.L.U.T. e.V. (Weingarten, Germany)

Celgene GmbH (Munich, Germany)

Bloodwise (United Kingdom)

EU's Seventh Framework Program (SyStemAge)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management;Garcia-Manero;Am J Hematol,2014

2. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals;Germing;Br J Haematol,2006

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome;Beran;Int J Hematol,2000

5. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia;Frontiers in Bioengineering and Biotechnology;2020-02-14

2. Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection;Nature Communications;2019-11-01

3. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion‐positive and fusion‐negative rhabdomyosarcoma;International Journal of Cancer;2019-01-15

4. Depletion of ZBTB38 potentiates the effects of DNA demethylating agents in cancer cells via CDKN1C mRNA up-regulation;Oncogenesis;2018-10

5. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases;International Journal of Molecular Sciences;2018-04-02